Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Camus (Dijon, France). Drug-induced ILD. Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders

Member's Comments

No comment yet.

Related content which might interest you: A young man with a respiratory distress Source: Annual Congress 2005 - Oncology Grand Round: an interactive session Year: 2005 Mechanisms of acute lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Proteinomics and ARDS Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside Year: 2007 Eosinophilic pneumonia (acute, chronic) Source: Respipedia Article Year: 2017 Prognosis of acute respiratory distress syndrome in neutropenic cancer patients Source: Eur Respir J 2012; 40: 169-176 Year: 2012 Acute lung injury as a possible adverse drug reaction related to gefitinib Source: Eur Respir J 2002 Jan 01;22(1):179-181 Year: 2003 Acute respiratory distress syndrome Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=49 Year: 2006 Ventilator-associated lung injury: a search for better therapeutic targets Source: Eur Respir J 2007; 30: 1216-1226 Year: 2007 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 b-Lactams and the lung Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=64 Year: 2004 Respiratory bronchiolitis-associated interstitial lung disease - RB-ILD Source: Respipedia Article Year: 2016 An integrated approach in the diagnosis of smoking-related interstitial lung diseases Source: Eur Respir Rev 2012 21:207-217 Year: 2012 Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus Source: Eur Respir J 2008; 31: 213-217 Year: 2008 Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005 Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008